We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Exhibits IVD Testing Solutions for POC and Critical Care at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)

Nova Biomedical (Waltham, MA, USA) is exhibiting its IVD testing solutions for point-of-care (POC) and critical care in the hospital and clinical areas at MEDICA 2022. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care.

On display at Nova’s booth is Allegro, a fast and compact POC capillary blood analyzer that offers a clinically important menu of 12 measured and individually selectable tests, as well as six calculated tests. All tests are measured with ready-to-use disposable cassettes or test strips and can be easily performed by non-technical personnel. Allegro uses a very small capillary blood drop for all blood tests, eliminating the need for venipuncture or a trained phlebotomist. With cartridge test times of six to nine minutes and the ability to measure two cartridges simultaneously, Allegro delivers fast results. Results are available during the patient visit - not after - making the patient-physician conversation more effective, reducing calls, letters and follow-up visits, and improving patient adherence to care recommendations.

Nova is also demonstrating EMS Stat, a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT. Stat EMS measures glucose, ketone bodies, lactate, hematocrit and hemoglobin from a capillary blood drop. Results are available within seconds, depending on the test. Combining disposable biosensor technology with portable electronics, Stat EMS provides simple, fast and accurate testing in the field. Stat EMS provides an important test menu for immediate patient assessment and faster, more effective emergency treatment. Stat EMS also assists in rapid triage and determining appropriate transport location for patients with trauma, sepsis or other special needs.

In addition, Nova is presenting the StatStrip Hemoglobin and Hematocrit Measurement System (StatStrip Hb/Hct), the only POC system that provides anemia screening and monitoring with measured rather than calculated Hb and Hct values. This important breakthrough is possible thanks to new, patented electrochemical technologies developed by Nova. Together with tiny capillary samples (1.6 µl) and results in 40 seconds, the StatStrip Hb/Hct improves clinical decision making at the POC. At MEDICA 2022, Nova is also showcasing BioProfile FLEX2 that combines Nova's breakthrough MicroSensor Card technology with optical sensing and freezing point osmometry to create an automated and comprehensive cell culture analyzer that eliminates chemical sensor maintenance, increases analyzer speed and reduces sample volume.

Related Links:
Nova Biomedical 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.